Texaphyrin conjugates and uses thereof
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 27, 2001
Grant Date -
N/A
app pub date -
Jun 4, 1999
filing date -
Jun 5, 1998
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Texaphyrin/chemotherapeutic drug conjugates, optionally including a platinum(II) or platinum(IV) metal chelating site and/or complex, are useful for treating atheroma, tumors and other neoplastic tissue, neovascular-related diseases, as well as other conditions that are typically responsive to chemotherapy, radiation sensitization and photodynamic therapy.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully